Current Market Information

Last Trade Price (LTP) 109.40 Last Trade Date 08 June, 2023 Change 9.95 % Open Price 99.50 Day's Range 103.00 - 109.40     Total Trade 174 Total Volume 26501 Close Price 109.40 Yesterday Close Price 99.50 Market Capital in BDT (mn) 11751.334

Contact Information

Designation Name Mobile Number Email Chairman Mr. Anisuzzaman Chowdhury 01816827875 anisuzzaman@navanapharma.com MD Professor. Dr. Md. Jonaid Shafiq 01321131190 Jonaid@navanapharma.com CEO Professor. Dr. Md. Jonaid Shafiq 01321131190 Jonaid@navanapharma.com CFO Mr. Md. Abu Hurayra FCA 01730016203 abu.hurayra@navanapharma.com Company Secretary Mr. Joynaul Abedin ACS 01708451980 joynul.acs@navanapharma.com Office Address 125/A, Motijheel C/A, Dhaka-1000 Phone : 02-55033580-3 Fax : 02-55033579 Email : cs@navanapharma.com Website : http://www.navanapharma.com Factory Address Rupshi, Rupganj, Narayanganj

Basic Information

Authorized Capital in BDT* (mn) 2,000.00 Paid-up Capital in BDT* (mn) 1,074.16 Face Value 10 Paid up Share 107416217     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 2022 Debut Trade Date 18 October, 2022 Type of Instrument Equity     52 Week's Range 26.40 - 122.90 Year End 202206 Reserve / Surplus(mn) 2680.74 Remarks Tk. 1,966,271,633 Revaluation Reserve has been added to Reserve & Surplus. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-May, 2023 35.49 0 13.38 27.74 23.39 As on 30-Apr, 2023 35.49 0 11.4 27.73 25.38 As on 31-Mar, 2023 35.49 0 9.06 27.73 27.72 As on 30-Jun, 2021 (year ended) 35.49 0 28.53 10.29 25.69     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company May 12, 2022 AA ST-2 Stable May 11, 2023 National Credit Rating Ltd.         Half Year End (HY) Information  202212 HY Net Turnover(mn)  2731.99 HY Net Profit after tax(mn)  143.56 HY EPS  1.57  AGM Information   AGM Date  22 December, 2022 Record Date  28 November, 2022 Dividend(%)  11.00 (Cash) Bonus Issue

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2021	2.52	0	1.88	0	41.19	37.74	202.29	0		0

Financial Statements
Quarterly Financial Statement	https://navanapharma.com/page/quarterly-accounts
Price Sensitive Information	https://navanapharma.com/page/psi

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To